Symbolbild · KI-generiert
VentriPoint Diagnostics Ltd.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Ventripoint Diagnostics Ltd. (TSXV: VPT, OTC: VPTDF) has become an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe and Canada.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| VentriPoint Diagnostics Ltd. | VPT | TSXV | 15 Mio. USD |
| Lobe Sciences Ltd. | LOBE | CSE | 15 Mio. USD |
| Conavi Medical Corp. | CNVI | TSXV | 15 Mio. USD |
| Alzai Health Corp. | ALZI | TSXV | 17 Mio. USD |
| Principal Technologies Inc. | PTEC | TSXV | 13 Mio. USD |
| MedX Health Corp. | MDX | TSXV | 13 Mio. USD |
| Nanalysis Scientific Corp. | NSCI | TSXV | 12 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.